Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19

J Am Acad Dermatol. 2020 Jul;83(1):e67-e68. doi: 10.1016/j.jaad.2020.04.097. Epub 2020 Apr 25.

Authors

Danielle Peterson¹, William Damsky², Brett King³

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: [email protected].
³ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: [email protected].

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections
Humans
Janus Kinase Inhibitors*
Pandemics
Pneumonia, Viral*
SARS-CoV-2

Substances

Janus Kinase Inhibitors

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States